PubMed COVID-19 Clinical Care

No abstract

CONCLUSION: The relationships identified in this exploratory correlational study suggest that COVID-19 had a negative impact on quality of life in individuals with traumatic brain injury, but not specifically on their social participation.

For targeted intervention in COVID-19, there is a high medical need for biomarkers that predict disease progression and severity in the first days after symptom onset. This study assessed the utility of early transforming growth factor β (TGFβ) serum

Covid-19 pandemic has influenced stroke care in different ways. Recent reports demonstrated a sharp decline in acute stroke admissions worldwide. Even for patients presented to dedicated healthcare services, management at the acute phase may be sub

SARS-CoV2 and the related disease COVID-19 had a dramatic impact on global healthcare system since its appearance in December 2019 [1]. The evidence of long-lasting sequelae in COVID-19 survivors have rapidly grown, leading to the current definition

Objective Advance care planning (ACP) is a process in which the patient and family discuss end-of-life care in advance with healthcare providers in case decisional ability declines. Due to the rapid deterioration of symptoms and isolation for

Drugs that target the main protease (M^(pro)) of SARS-CoV-2 are effective therapeutics that have entered clinical use. Wide-scale use of these drugs will apply selection pressure for the evolution of resistance mutations. To understand resistance

Over the course of the COVID-19 pandemic, people have realized the importance of wearing a mask. However, conventional nanofiber-based face masks impede communication between people because of their opacity. Moreover, it remains challenging to

The use of face mask is essential in COVID-19 era. During this period for cosmetic procedure on the face, the mask should be of small size and easily procured to maximize the exposure of the face especially in girls going to get married having

Persistent symptomatic coronavirus disease 2019 (COVID-19) is a distinct clinical entity among patients with hematologic cancer and/or profound immunosuppression. The optimal medical management is unknown. We describe 2 patients who had symptomatic